female sexual dysfunction
For More Medicine Free PPT - http://playnever.blogspot.com/
For Health benefits and medicine videos Subscribe youtube channel - https://www.youtube.com/playlist?list=PLKg-H-sMh9G01zEg4YpndngXODW2bq92w
Premature ejaculation is a common male sexual dysfunction characterized by the inability to delay ejaculation and can cause distress. It is classified as lifelong or acquired and has prevalence rates ranging from 2-33% depending on age and region. While the exact etiology is unknown, potential contributing factors include anxiety, penile hypersensitivity, serotonin receptor dysfunction, and multifactorial biological and psychosocial influences. Diagnosis involves assessing ejaculation latency, distress levels, and ruling out other conditions. Treatment options include behavioral techniques, pharmacotherapy like SSRIs, and counseling with success rates over 85% depending on commitment to therapy. Prognosis is generally good but relapse can occur without ongoing management.
Female sexual dysfunction is common, affecting approximately 40% of women worldwide. It includes decreased sexual desire, arousal issues, inability to orgasm, and genital pain. It is caused by hormonal imbalances, neurological or vascular problems, relationship issues, stress, abuse history, and psychiatric disorders. Treatment depends on the specific issue, but may include hormones, drugs to increase arousal or desire, physical therapy, pain management, relationship counseling, and surgery in some cases. An accurate diagnosis is based on a thorough history and ruling out other potential medical causes.
Loss of libido, or decreased sex drive, is common and can affect about 1 in 5 men and more women at some point in their lives. Common causes include relationship problems, stress, depression, drugs/alcohol, aging, hormonal imbalances, medical conditions, and certain medications. As people age, sex hormone levels decline which can reduce libido, and conditions like depression or medications for depression can also negatively impact sex drive. Relationship issues, stress, exhaustion, depression, excess alcohol, medical conditions, and some medications are among the most frequent causes of low libido.
This document provides information about premature ejaculation (PE), including its causes, diagnosis, and treatment options. PE is characterized by a lack of control over ejaculation and many men experience it occasionally. It is controlled by the central nervous system and can have psychological or biological causes like serotonin levels. Treatments include behavioral therapies like squeeze or stop-start methods, medications like antidepressants, and anesthetic creams applied to the penis. Psychological therapy can also help address relationship issues that may contribute to PE.
1. The physiology of ejaculation involves complex interactions between the central nervous system and peripheral pathways. It has two phases - emission and expulsion.
2. Premature ejaculation is defined as ejaculation that occurs within about one minute of penetration, the inability to delay ejaculation, and negative personal consequences.
3. The pathophysiology of premature ejaculation is multifactorial and not fully understood but likely involves genetic factors, psychological states like anxiety, and alterations in hormones like serotonin and testosterone.
This document defines vaginismus and discusses its diagnosis and treatment. It begins by defining vaginismus and tracing the evolution of its definition. It notes that vaginismus is characterized by involuntary contraction of pelvic floor muscles that interfere with penetration. The document discusses prevalence, types, potential causes, diagnosis through history and examination, and classification. It outlines treatment approaches including exploration of underlying phobias or beliefs, sex education, muscle relaxation exercises, and systematic vaginal desensitization using graduated insertion of trainers under controlled relaxation. The goal of treatment is to help women gain control of pelvic floor muscles and replace pain with pleasure through a multidisciplinary approach.
The document discusses male sexual dysfunction and provides details about the male sexual response cycle and various sexual disorders that can affect men. It describes the five stages of the male sexual response cycle: arousal, plateau, orgasm, resolution, and refractory period. It then discusses several types of sexual dysfunctions men can experience, including disorders of desire (hypersexual disorder, hypoactive sexual desire, sexual aversion), arousal disorders (erectile dysfunction, erectile dyspareunia), and ejaculatory disorders (premature ejaculation, retarded ejaculation, ejaculatory incompetence, retrograde ejaculation, ejaculatory dyspareunia). For each disorder, it provides the clinical definition and discusses potential
female sexual dysfunction
For More Medicine Free PPT - http://playnever.blogspot.com/
For Health benefits and medicine videos Subscribe youtube channel - https://www.youtube.com/playlist?list=PLKg-H-sMh9G01zEg4YpndngXODW2bq92w
Premature ejaculation is a common male sexual dysfunction characterized by the inability to delay ejaculation and can cause distress. It is classified as lifelong or acquired and has prevalence rates ranging from 2-33% depending on age and region. While the exact etiology is unknown, potential contributing factors include anxiety, penile hypersensitivity, serotonin receptor dysfunction, and multifactorial biological and psychosocial influences. Diagnosis involves assessing ejaculation latency, distress levels, and ruling out other conditions. Treatment options include behavioral techniques, pharmacotherapy like SSRIs, and counseling with success rates over 85% depending on commitment to therapy. Prognosis is generally good but relapse can occur without ongoing management.
Female sexual dysfunction is common, affecting approximately 40% of women worldwide. It includes decreased sexual desire, arousal issues, inability to orgasm, and genital pain. It is caused by hormonal imbalances, neurological or vascular problems, relationship issues, stress, abuse history, and psychiatric disorders. Treatment depends on the specific issue, but may include hormones, drugs to increase arousal or desire, physical therapy, pain management, relationship counseling, and surgery in some cases. An accurate diagnosis is based on a thorough history and ruling out other potential medical causes.
Loss of libido, or decreased sex drive, is common and can affect about 1 in 5 men and more women at some point in their lives. Common causes include relationship problems, stress, depression, drugs/alcohol, aging, hormonal imbalances, medical conditions, and certain medications. As people age, sex hormone levels decline which can reduce libido, and conditions like depression or medications for depression can also negatively impact sex drive. Relationship issues, stress, exhaustion, depression, excess alcohol, medical conditions, and some medications are among the most frequent causes of low libido.
This document provides information about premature ejaculation (PE), including its causes, diagnosis, and treatment options. PE is characterized by a lack of control over ejaculation and many men experience it occasionally. It is controlled by the central nervous system and can have psychological or biological causes like serotonin levels. Treatments include behavioral therapies like squeeze or stop-start methods, medications like antidepressants, and anesthetic creams applied to the penis. Psychological therapy can also help address relationship issues that may contribute to PE.
1. The physiology of ejaculation involves complex interactions between the central nervous system and peripheral pathways. It has two phases - emission and expulsion.
2. Premature ejaculation is defined as ejaculation that occurs within about one minute of penetration, the inability to delay ejaculation, and negative personal consequences.
3. The pathophysiology of premature ejaculation is multifactorial and not fully understood but likely involves genetic factors, psychological states like anxiety, and alterations in hormones like serotonin and testosterone.
This document defines vaginismus and discusses its diagnosis and treatment. It begins by defining vaginismus and tracing the evolution of its definition. It notes that vaginismus is characterized by involuntary contraction of pelvic floor muscles that interfere with penetration. The document discusses prevalence, types, potential causes, diagnosis through history and examination, and classification. It outlines treatment approaches including exploration of underlying phobias or beliefs, sex education, muscle relaxation exercises, and systematic vaginal desensitization using graduated insertion of trainers under controlled relaxation. The goal of treatment is to help women gain control of pelvic floor muscles and replace pain with pleasure through a multidisciplinary approach.
The document discusses male sexual dysfunction and provides details about the male sexual response cycle and various sexual disorders that can affect men. It describes the five stages of the male sexual response cycle: arousal, plateau, orgasm, resolution, and refractory period. It then discusses several types of sexual dysfunctions men can experience, including disorders of desire (hypersexual disorder, hypoactive sexual desire, sexual aversion), arousal disorders (erectile dysfunction, erectile dyspareunia), and ejaculatory disorders (premature ejaculation, retarded ejaculation, ejaculatory incompetence, retrograde ejaculation, ejaculatory dyspareunia). For each disorder, it provides the clinical definition and discusses potential
This document discusses male infertility and impotence. It notes that 50% of infertility cases are due to female factors, 30% are due to male factors, and 20% are due to combined factors. It outlines the evaluation process for male infertility, including medical history, physical exam, laboratory tests, imaging, and semen analysis. Potential causes of male infertility include pretesticular, testicular, and post-testicular issues. Treatment options discussed include both medical and surgical approaches. The document also discusses erectile dysfunction, noting its increasing incidence with age, anatomy, physiology, causes, diagnosis, and various treatment approaches.
Erectile Dysfunction Symptoms And TreatmentManas Das
This presentation describes Symptoms And Treatment of Erectile Dysfunction which is a very common diseases in men.Erectile Dysfunction can be cure easily if proper treatment will be taken.To identify Erectile Dysfunction some symptoms are there which can help you.
Ejaculation involves three phases - emission, bladder neck contraction, and expulsion. Premature ejaculation (PE) is defined as ejaculation occurring within about 1 minute of penetration that the man has little control over, causing distress. The pathophysiology of PE is not fully understood but may involve genetic, psychological, hormonal, penile sensitivity, and prostatic factors. PE is diagnosed based on history and can be evaluated using tools like the Premature Ejaculation Diagnostic Tool. Treatment includes behavioral therapies like stop-start and squeeze techniques as well as pharmacotherapies.
1. Puberty is defined as the transitional stage from childhood to adulthood that is characterized by physiological changes and development of secondary sex characteristics.
2. It typically occurs between ages 10-16 and is influenced by genetic and environmental factors such as nutrition, geography, and light exposure.
3. The stages of puberty include thelarche, adrenarche, growth spurt, menarche, and development of secondary sex characteristics over approximately 4.5 years.
This document discusses various aspects of female sexual function and dysfunction, including physiology, models of sexual response, phases of sexual response, and instruments used to assess female sexual dysfunction. It provides details on several validated questionnaires used to evaluate female sexual function, including the Female Sexual Function Index, Changes in Sexual Functioning Questionnaire, Derogatis Interview for Sexual Functioning, and Sexual Quality of Life-Female Questionnaire. It also discusses components of clinical evaluation for female sexual dysfunction, such as history, physical exam, lab tests, and treatment options.
This document discusses normal and abnormal vaginal discharge, also known as leukorrhea. Normal discharge is creamy white and varies throughout a woman's menstrual cycle and with sexual arousal. Increased discharge can be physiological during times like pregnancy or due to factors like contraceptive use. Pathological discharge is caused by conditions like vaginitis in children, atrophic vaginitis/senile vaginitis in postmenopausal women, candidiasis, bacterial vaginosis, trichomonas vaginitis, mucopurulent cervicitis, foreign bodies, neoplasms, or urinary/fecal incontinence. These conditions present with different symptoms and require diagnostic testing and specific treatment approaches.
This document provides information on erectile dysfunction (ED), including its definition, causes, evaluation, and treatment options. It defines ED as the persistent inability to attain or maintain an erection sufficient for sexual activity. ED can be caused by physical factors like vascular disease or neurological issues, as well as psychological factors like depression or relationship problems. Evaluation involves a medical history, physical exam, and sometimes lab tests or nocturnal penile tumescence testing. Treatment ranges from lifestyle changes and oral medications to devices like pumps or implants. The goal is to help patients achieve erections sufficient for sexual intercourse.
Congenital malformations of female genital tractSalini Mandal
This document discusses various congenital malformations of the female genital tract that can occur, including anomalies of the external genitalia, vagina, uterus, fallopian tubes, and ovaries. Some key malformations mentioned are imperforate hymen, transverse vaginal septum, bicornuate and septate uteri, elongated or absent fallopian tubes, and streak gonads. The causes are often genetic in origin. Clinical features may include infertility, dyspareunia, abnormal bleeding, recurrent miscarriage, and obstructed labor. Treatment depends on the specific anomaly but may involve surgical correction or resection.
This document discusses female infertility, including definitions of primary and secondary infertility, common causes, and initial investigations for infertile couples. It covers testing for ovulation and tubal patency, as well as the roles of laparoscopy and hysteroscopy. Tests of ovulation include LH kits, progesterone assays, basal body temperature tracking, examining cervical mucus, and transvaginal ultrasounds. Tests of tubal patency comprise hysterosalpingography, laparoscopy with dye tests, and sonohysterosalpingography.
Primary amenorrhea is defined as the absence of menstruation by age 14 with no secondary sex characteristics or by age 16 with or without secondary sex characteristics. Secondary amenorrhea is defined as the absence of menstruation for 6 months or more after menstruating previously. The document provides detailed information on the causes, diagnosis, and treatment of primary and secondary amenorrhea. For primary amenorrhea, the most common causes are chromosomal abnormalities, hypothalamic hypogonadism, and Mullerian agenesis. The diagnosis involves assessing secondary sex characteristics, family history, laboratory tests of FSH, prolactin and thyroid levels, and imaging tests. Treatment focuses on treating the underlying cause and replacing any
This document provides guidance on evaluating and diagnosing the causes of vaginal discharge. It discusses the most common causes as bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis. For patients presenting with vaginal discharge, the clinician should obtain a thorough medical history and perform a physical exam. Diagnosis involves assessing symptoms, performing a pH test and microscopic examination of vaginal secretions. Treatment involves antibiotics for bacterial infections like BV, antifungals for candidiasis, and partners should be treated for trichomoniasis and other sexually transmitted infections. A case example is presented of a patient diagnosed with trichomoniasis based on symptoms and wet mount exam
Infertility is defined as the inability to conceive after one year of unprotected intercourse. It can be caused by issues with ovulation, the fallopian tubes, uterus, cervix, or vagina in women or by low sperm count or quality, obstruction, or ejaculation issues in men. Diagnostic evaluation involves medical histories, physical exams, and lab tests of both partners. Treatment may include medications to stimulate ovulation, artificial insemination, in vitro fertilization, gamete intrafallopian transfer, or zygote intrafallopian transfer depending on the causes of infertility.
Delayed Puberty Topics in Adolescent Gynecology Delayed Puberty Topics in A...MedicineAndHealth14
This document discusses delayed puberty in adolescent girls. It begins by outlining normal pubertal development and defining delayed puberty. Delayed puberty is then classified into three categories: hypergonadotropic hypogonadism (43%), hypogonadotropic hypogonadism (31%), and eugonadism (26%). For evaluation and management, the document recommends obtaining a history, physical exam, initial labs (TSH, prolactin), and a progestational challenge to determine gonadotropin levels and identify underlying causes. Treatment strategies aim to correct the underlying pathology, prevent disease complications, and provide sex steroids.
Vaginismus is an involuntary spasm of the outer third of the vagina that interferes with sexual intercourse. It has psychological and physical causes and can develop from traumatic experiences, sexual abuse, or religious beliefs. Treatment involves breaking the pain-anxiety cycle through sex education, muscle relaxation exercises, and the gradual insertion of dilators under the woman's control to desensitize the vagina to penetration. The goal is to help the woman feel comfortable owning her body and sharing it through a process that respects her pace and limits anxiety, with success rates of around 90% through systematic desensitization. Surgery is rarely needed and may worsen the condition.
This document discusses abnormal uterine bleeding (AUB). It defines AUB and normal menstruation. It describes various clinical types of AUB and potential causes. Evaluation involves history, examination, and investigations. Treatment options include medical approaches like hormonal therapies and surgical procedures like endometrial ablation. Dysfunctional uterine bleeding is discussed in depth as the most common cause of AUB.
Hormone replacement therapy (HRT) can help relieve menopausal symptoms, prevent osteoporosis, and maintain quality of life during menopause. It is recommended for women experiencing premature menopause or those who had surgical menopause. HRT improves hot flashes, urogenital atrophy, and bone mineral density while reducing risks of fractures, colorectal cancer, and possibly heart disease. However, HRT may increase risks of blood clots, breast cancer, gallbladder disease, and dementia. The benefits and risks depend on dosage and treatment duration, so the lowest effective dose is recommended for short periods of time.
This document defines premenstrual syndrome and discusses its prevalence, etiology, diagnosis, and management. Some key points include:
- PMS involves physical, psychological, and behavioral symptoms that occur during the luteal phase of the menstrual cycle and go away during menstruation.
- About 15% of women have no PMS symptoms, 50% have mild symptoms, 30% have moderate symptoms, and 5-10% have severe symptoms.
- Management includes lifestyle changes, dietary supplements, exercise, stress reduction, hormonal treatments, antidepressants, and in severe cases, surgery. Cognitive behavioral therapy provides long-term benefits.
This clinical guideline outlines an approach for evaluating and managing amenorrhea. Amenorrhea is classified as primary or secondary. The workup involves excluding pregnancy, cryptomenorrhea, and obtaining a history, physical exam, and ultrasound. Patients are categorized based on secondary sex characteristics, androgen levels, and test results to identify endocrine abnormalities. Management aims to restore ovulation if possible or provide hormone replacement therapy to prevent health issues. Frequent reevaluation is important given the various potential causes.
This document discusses disorders of menstruation, including amenorrhea (absence of menstrual period), premenstrual syndrome (PMS), and menorrhagia (heavy menstrual bleeding). Amenorrhea can be primary (periods never start) or secondary (periods stop) and has many potential causes including pregnancy, breastfeeding, menopause, hormonal imbalances, medications, and structural issues. PMS involves physical and emotional symptoms in the one to two weeks before a woman's period, and is thought to be related to cyclic hormone changes. Menorrhagia is heavy or prolonged bleeding and can be caused by hormone imbalances, uterine fibroids, polyps, medications, and other medical conditions. Diagn
The document discusses sexual dysfunction and the sexual response cycle. It defines sexual dysfunction, outlines the typical sexual response cycle and phases of arousal, orgasm and resolution. It describes various dysfunctions like reduced libido, arousal issues, premature ejaculation and anorgasmia. Causes include psychological, relationship, medical and medication factors. Evaluation involves history, exam and sometimes labs. Treatment focuses on addressing underlying causes, education, counseling/therapy, and sometimes medications.
This document discusses aging and sexual function. It notes that as people live longer, more remain sexually active in late life. The five stages of sexual response are described. Common age-related changes are then outlined for both men and women, including declining testosterone levels in men and menopausal changes in women. Late life sexual dysfunctions are often multifactorial, caused by medical issues, medications, or psychological factors. Evaluation and treatments are discussed for common problems like low sexual desire, pain with penetration, and difficulty reaching orgasm. Maintaining open communication and understanding of changes can help couples have satisfying sexual relationships in late life.
This document discusses male infertility and impotence. It notes that 50% of infertility cases are due to female factors, 30% are due to male factors, and 20% are due to combined factors. It outlines the evaluation process for male infertility, including medical history, physical exam, laboratory tests, imaging, and semen analysis. Potential causes of male infertility include pretesticular, testicular, and post-testicular issues. Treatment options discussed include both medical and surgical approaches. The document also discusses erectile dysfunction, noting its increasing incidence with age, anatomy, physiology, causes, diagnosis, and various treatment approaches.
Erectile Dysfunction Symptoms And TreatmentManas Das
This presentation describes Symptoms And Treatment of Erectile Dysfunction which is a very common diseases in men.Erectile Dysfunction can be cure easily if proper treatment will be taken.To identify Erectile Dysfunction some symptoms are there which can help you.
Ejaculation involves three phases - emission, bladder neck contraction, and expulsion. Premature ejaculation (PE) is defined as ejaculation occurring within about 1 minute of penetration that the man has little control over, causing distress. The pathophysiology of PE is not fully understood but may involve genetic, psychological, hormonal, penile sensitivity, and prostatic factors. PE is diagnosed based on history and can be evaluated using tools like the Premature Ejaculation Diagnostic Tool. Treatment includes behavioral therapies like stop-start and squeeze techniques as well as pharmacotherapies.
1. Puberty is defined as the transitional stage from childhood to adulthood that is characterized by physiological changes and development of secondary sex characteristics.
2. It typically occurs between ages 10-16 and is influenced by genetic and environmental factors such as nutrition, geography, and light exposure.
3. The stages of puberty include thelarche, adrenarche, growth spurt, menarche, and development of secondary sex characteristics over approximately 4.5 years.
This document discusses various aspects of female sexual function and dysfunction, including physiology, models of sexual response, phases of sexual response, and instruments used to assess female sexual dysfunction. It provides details on several validated questionnaires used to evaluate female sexual function, including the Female Sexual Function Index, Changes in Sexual Functioning Questionnaire, Derogatis Interview for Sexual Functioning, and Sexual Quality of Life-Female Questionnaire. It also discusses components of clinical evaluation for female sexual dysfunction, such as history, physical exam, lab tests, and treatment options.
This document discusses normal and abnormal vaginal discharge, also known as leukorrhea. Normal discharge is creamy white and varies throughout a woman's menstrual cycle and with sexual arousal. Increased discharge can be physiological during times like pregnancy or due to factors like contraceptive use. Pathological discharge is caused by conditions like vaginitis in children, atrophic vaginitis/senile vaginitis in postmenopausal women, candidiasis, bacterial vaginosis, trichomonas vaginitis, mucopurulent cervicitis, foreign bodies, neoplasms, or urinary/fecal incontinence. These conditions present with different symptoms and require diagnostic testing and specific treatment approaches.
This document provides information on erectile dysfunction (ED), including its definition, causes, evaluation, and treatment options. It defines ED as the persistent inability to attain or maintain an erection sufficient for sexual activity. ED can be caused by physical factors like vascular disease or neurological issues, as well as psychological factors like depression or relationship problems. Evaluation involves a medical history, physical exam, and sometimes lab tests or nocturnal penile tumescence testing. Treatment ranges from lifestyle changes and oral medications to devices like pumps or implants. The goal is to help patients achieve erections sufficient for sexual intercourse.
Congenital malformations of female genital tractSalini Mandal
This document discusses various congenital malformations of the female genital tract that can occur, including anomalies of the external genitalia, vagina, uterus, fallopian tubes, and ovaries. Some key malformations mentioned are imperforate hymen, transverse vaginal septum, bicornuate and septate uteri, elongated or absent fallopian tubes, and streak gonads. The causes are often genetic in origin. Clinical features may include infertility, dyspareunia, abnormal bleeding, recurrent miscarriage, and obstructed labor. Treatment depends on the specific anomaly but may involve surgical correction or resection.
This document discusses female infertility, including definitions of primary and secondary infertility, common causes, and initial investigations for infertile couples. It covers testing for ovulation and tubal patency, as well as the roles of laparoscopy and hysteroscopy. Tests of ovulation include LH kits, progesterone assays, basal body temperature tracking, examining cervical mucus, and transvaginal ultrasounds. Tests of tubal patency comprise hysterosalpingography, laparoscopy with dye tests, and sonohysterosalpingography.
Primary amenorrhea is defined as the absence of menstruation by age 14 with no secondary sex characteristics or by age 16 with or without secondary sex characteristics. Secondary amenorrhea is defined as the absence of menstruation for 6 months or more after menstruating previously. The document provides detailed information on the causes, diagnosis, and treatment of primary and secondary amenorrhea. For primary amenorrhea, the most common causes are chromosomal abnormalities, hypothalamic hypogonadism, and Mullerian agenesis. The diagnosis involves assessing secondary sex characteristics, family history, laboratory tests of FSH, prolactin and thyroid levels, and imaging tests. Treatment focuses on treating the underlying cause and replacing any
This document provides guidance on evaluating and diagnosing the causes of vaginal discharge. It discusses the most common causes as bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis. For patients presenting with vaginal discharge, the clinician should obtain a thorough medical history and perform a physical exam. Diagnosis involves assessing symptoms, performing a pH test and microscopic examination of vaginal secretions. Treatment involves antibiotics for bacterial infections like BV, antifungals for candidiasis, and partners should be treated for trichomoniasis and other sexually transmitted infections. A case example is presented of a patient diagnosed with trichomoniasis based on symptoms and wet mount exam
Infertility is defined as the inability to conceive after one year of unprotected intercourse. It can be caused by issues with ovulation, the fallopian tubes, uterus, cervix, or vagina in women or by low sperm count or quality, obstruction, or ejaculation issues in men. Diagnostic evaluation involves medical histories, physical exams, and lab tests of both partners. Treatment may include medications to stimulate ovulation, artificial insemination, in vitro fertilization, gamete intrafallopian transfer, or zygote intrafallopian transfer depending on the causes of infertility.
Delayed Puberty Topics in Adolescent Gynecology Delayed Puberty Topics in A...MedicineAndHealth14
This document discusses delayed puberty in adolescent girls. It begins by outlining normal pubertal development and defining delayed puberty. Delayed puberty is then classified into three categories: hypergonadotropic hypogonadism (43%), hypogonadotropic hypogonadism (31%), and eugonadism (26%). For evaluation and management, the document recommends obtaining a history, physical exam, initial labs (TSH, prolactin), and a progestational challenge to determine gonadotropin levels and identify underlying causes. Treatment strategies aim to correct the underlying pathology, prevent disease complications, and provide sex steroids.
Vaginismus is an involuntary spasm of the outer third of the vagina that interferes with sexual intercourse. It has psychological and physical causes and can develop from traumatic experiences, sexual abuse, or religious beliefs. Treatment involves breaking the pain-anxiety cycle through sex education, muscle relaxation exercises, and the gradual insertion of dilators under the woman's control to desensitize the vagina to penetration. The goal is to help the woman feel comfortable owning her body and sharing it through a process that respects her pace and limits anxiety, with success rates of around 90% through systematic desensitization. Surgery is rarely needed and may worsen the condition.
This document discusses abnormal uterine bleeding (AUB). It defines AUB and normal menstruation. It describes various clinical types of AUB and potential causes. Evaluation involves history, examination, and investigations. Treatment options include medical approaches like hormonal therapies and surgical procedures like endometrial ablation. Dysfunctional uterine bleeding is discussed in depth as the most common cause of AUB.
Hormone replacement therapy (HRT) can help relieve menopausal symptoms, prevent osteoporosis, and maintain quality of life during menopause. It is recommended for women experiencing premature menopause or those who had surgical menopause. HRT improves hot flashes, urogenital atrophy, and bone mineral density while reducing risks of fractures, colorectal cancer, and possibly heart disease. However, HRT may increase risks of blood clots, breast cancer, gallbladder disease, and dementia. The benefits and risks depend on dosage and treatment duration, so the lowest effective dose is recommended for short periods of time.
This document defines premenstrual syndrome and discusses its prevalence, etiology, diagnosis, and management. Some key points include:
- PMS involves physical, psychological, and behavioral symptoms that occur during the luteal phase of the menstrual cycle and go away during menstruation.
- About 15% of women have no PMS symptoms, 50% have mild symptoms, 30% have moderate symptoms, and 5-10% have severe symptoms.
- Management includes lifestyle changes, dietary supplements, exercise, stress reduction, hormonal treatments, antidepressants, and in severe cases, surgery. Cognitive behavioral therapy provides long-term benefits.
This clinical guideline outlines an approach for evaluating and managing amenorrhea. Amenorrhea is classified as primary or secondary. The workup involves excluding pregnancy, cryptomenorrhea, and obtaining a history, physical exam, and ultrasound. Patients are categorized based on secondary sex characteristics, androgen levels, and test results to identify endocrine abnormalities. Management aims to restore ovulation if possible or provide hormone replacement therapy to prevent health issues. Frequent reevaluation is important given the various potential causes.
This document discusses disorders of menstruation, including amenorrhea (absence of menstrual period), premenstrual syndrome (PMS), and menorrhagia (heavy menstrual bleeding). Amenorrhea can be primary (periods never start) or secondary (periods stop) and has many potential causes including pregnancy, breastfeeding, menopause, hormonal imbalances, medications, and structural issues. PMS involves physical and emotional symptoms in the one to two weeks before a woman's period, and is thought to be related to cyclic hormone changes. Menorrhagia is heavy or prolonged bleeding and can be caused by hormone imbalances, uterine fibroids, polyps, medications, and other medical conditions. Diagn
The document discusses sexual dysfunction and the sexual response cycle. It defines sexual dysfunction, outlines the typical sexual response cycle and phases of arousal, orgasm and resolution. It describes various dysfunctions like reduced libido, arousal issues, premature ejaculation and anorgasmia. Causes include psychological, relationship, medical and medication factors. Evaluation involves history, exam and sometimes labs. Treatment focuses on addressing underlying causes, education, counseling/therapy, and sometimes medications.
This document discusses aging and sexual function. It notes that as people live longer, more remain sexually active in late life. The five stages of sexual response are described. Common age-related changes are then outlined for both men and women, including declining testosterone levels in men and menopausal changes in women. Late life sexual dysfunctions are often multifactorial, caused by medical issues, medications, or psychological factors. Evaluation and treatments are discussed for common problems like low sexual desire, pain with penetration, and difficulty reaching orgasm. Maintaining open communication and understanding of changes can help couples have satisfying sexual relationships in late life.
Female Sexual Interest/ Arousal Disorder- ManagementSujoy Dasgupta
Invited lecture by Dr Sujoy Dasgupta in a Webinar on "Female Sexual Dysfunction" organized by FOGSI Sexual Medicine Committee, Falidabad, Palwal and Yamuna Nagar OBGYN Society, held in August, 2021
This document summarizes a presentation given by Dr. Martha Tara Lee on sexuality in obstetrics and gynecology. It discusses Dr. Lee's background and credentials in human sexuality. The presentation covers topics like what is sexology, common sexological issues, models for addressing sexual concerns, female sexual dysfunctions, myths about sexuality, and cultural influences on sexuality. Treatment suggestions are provided for issues like low sexual desire. The goal is to have an educational yet non-judgmental approach to discussing sexuality issues.
This document discusses male sexual dysfunction in multiple sclerosis (MS), including loss of libido, ejaculatory issues, infertility problems, and erectile dysfunction. It notes that 55% of males with MS report sexual dysfunction, most commonly lack of sexual interest and erectile dysfunction. The document outlines various types of sexual dysfunction and their neurological causes. It also discusses evaluations, treatments, and management strategies for different sexual issues like premature ejaculation, retrograde ejaculation, and erectile dysfunction. Treatments may include counseling, medications like phosphodiesterase type 5 inhibitors, penile rehabilitation exercises, and assistive devices.
Sexual Disorders & Gender Identity Disorder (2).pptxTracyLewis48
This document provides information about sexual disorders and treatments. It discusses several types of sexual dysfunctions including disorders of desire, excitement, orgasm, and pain. Common causes are biological, psychological, and sociocultural factors. Treatments discussed include sex therapy, medications, and addressing physical or medical issues. The document also covers paraphilic disorders such as fetishism, exhibitionism, voyeurism, frotteurism, pedophilia, sexual masochism, and sadism. Causes may include psychodynamic issues, classical conditioning, or modeling behaviors.
Sexual Disorders & Gender Identity Disorder.pptxTracyLewis47
This document provides information about sexual disorders and treatments. It discusses several types of sexual dysfunctions including disorders of desire, excitement, orgasm and pain. It outlines their causes such as biological factors, psychological issues and sociocultural influences. The document also reviews treatments for sexual dysfunctions like sex therapy, medications, and therapies for specific disorders. Additionally, it covers paraphilic disorders and gender identity disorder.
This document defines Hypoactive Sexual Desire Disorder (HSDD) in men and discusses its epidemiology, physiology, etiology, assessment, and treatment. HSDD is characterized by persistently low sexual desire, absent sexual thoughts or fantasies, and lack of responsive desire lasting at least 6 months. It can be lifelong or acquired, generalized or situational. Potential causes include depression, stress, medical conditions, and certain medications. Treatment involves a biopsychosocial approach including counseling, medication management, lifestyle changes, and addressing relationship factors.
Psychogenic impotence, also known as erectile dysfunction, has various potential causes including performance anxiety, relationship issues, medical conditions, and psychological factors. It is important to conduct a thorough sexual history and examination to determine if the cause is organic or psychogenic. Treatment may involve lifestyle changes, psychotherapy to reduce anxiety, cognitive behavioral therapy, and medications like PDE5 inhibitors. A multidisciplinary approach including medical treatment, counseling, and lifestyle modifications often provides the best outcomes.
Sexual disorders can take many forms and have various underlying causes. They are broadly classified into four categories: gender identity disorders, paraphilias, psychopathological disorders of sexual development/maturation, and sexual dysfunctions. Common types of sexual disorders include lack of sexual desire, difficulties achieving or maintaining arousal/erection, premature ejaculation, and pain during sex. Factors contributing to sexual disorders can be physical, psychological, or social in nature. Treatment depends on the specific disorder but may involve counseling, therapy, or medication.
"Treatment Concepts and Techniques in Sexual Therapy" by Clinical Sexologist Dr. Martha Tara Lee of Eros Coaching for "Symposium - Sex and the Spine: All You Ever Wanted to Know about Sex and the Spine but Were Afraid to Ask" by NSpine as part of SpineWeek, at Marina Bay Sands Expo & Convention Centre on Mon 16 May 2016.
Dr Martha Tara Lee is Founder and Clinical Sexologist of Eros Coaching since 2009. She is a certified sexologist with ACS (American College of Sexologists), as well as a certified sexuality educator with AASECT (American Association of Sexuality Educators, Counselors, and Therapists). Martha holds a Doctorate in Human Sexuality as well as Certificates in Sex Therapy, Practical Counselling and Life Coaching. She was recognised as one of ‘Top 50 Inspiring Women under 40′ by Her World Singapore in July 2010 and ‘Top 100 Inspiring Women by CozyCot Singapore in March 2011. Website: http://www.eroscoaching.com.
Overview: Sexual dysfunction; sexual response cycle; types of sexual dysfunction - male: erectile dysfunction, pre-mature ejaculation, ejaculatory incompetence and female: vaginismus, dyspareunia, anorgasmia; causes- organic and psychosocial factors and management: sensate focus and management of specific dysfunction.
Invited lecture by Dr Sujoy Dasgupta in the Webinar on "Sexual Dysfunction" organized by the BOGS (Bengal Obstetric and Gynaecological Society) and the Sexual Medicine Committee of FOGSI (federation of Obstetric and Gynaecological Societies of India) held in September, 2021
Sexual dysfunctions are defined as the inability to participate in sexual relationships as desired or the experience of distressing sexual problems that are persistent and recurrent. The DSM-5 categorizes four main types of sexual dysfunctions: sexual desire disorders, sexual arousal disorders, orgasmic disorders, and sexual pain disorders. Assessment of sexual dysfunctions involves considering medical, psychological, relational, and cultural factors, with treatment tailored based on the identified causes.
Couple therapy can effectively treat sexual dysfunctions by addressing the four stages of the human sexual response cycle described by Masters and Johnson: excitement, plateau, orgasm, and resolution. Common female sexual dysfunctions addressed in therapy include hypoactive sexual desire disorder, female sexual arousal disorder, orgasmic disorder, and painful intercourse disorders. Common male dysfunctions treated include premature ejaculation, erectile dysfunction, and hypoactive sexual desire disorder. Treatment involves addressing psychological, medical, relationship, and intimacy factors that may be contributing to the sexual issues.
This document summarizes key points about hormones and the brain in relation to sexual arousal and response. It discusses how testosterone and estrogen influence male and female libido. The limbic system and neurotransmitters like dopamine and oxytocin facilitate sexual arousal. Visual, tactile, and olfactory senses can stimulate arousal depending on cultural conditioning. The document also describes Masters and Johnson's four phase model of sexual response and changes in male and female anatomy that occur during each phase. It addresses historical misconceptions about female sexuality and explores the purported "G-spot".
Frigid & Frustrated @ to a group of endocrinologists at Mt Elizabeth Hospital in 16 Nov 2014.
Dr Martha Tara Lee is Founder and Clinical Sexologist of Eros Coaching since 2009. She is a certified sexologist with ACS (American College of Sexologists), as well as a certified sexuality educator with AASECT (American Association of Sexuality Educators, Counselors, and Therapists). Martha holds a Doctorate in Human Sexuality as well as Certificates in Sex Therapy, Practical Counselling and Life Coaching. She was recognised as one of ‘Top 50 Inspiring Women under 40′ by Her World Singapore in July 2010 and ‘Top 100 Inspiring Women by CozyCot Singapore in March 2011. Website: http://www.eroscoaching.com.
Drugs which affecting sexual health may be a big problem and must keep it in your mind before prescribing a medication
Monitoring and treatment of drug induced sexual dysfunction is important step if the physician can not stop the causative agent
Dr. Aaron Spitz's presentation as Associate Professor at UCI Urology. This presentation covers how couples can work together to improve their sexual health.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Dr Sujoy Dasgupta was invited to deliver a lecture on "Male Infertility, Antioxidants and Beyond" on 3 February in Yuvacon 2024 organized by the Bengal Obstetric and Gynaecological Society (BOGS). The session was supported by UNS.
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
Dr Sujoy Dasgupta participated in an invited debate FOR the motion "Radical excision of DIE in subferile women with deep infiltrating endometriosis is not recommended" in ENDOGYN 2024, organized by the IAGE (Indian Association of Gynaecological Endoscopists) and the BOGS (Bengal Obstetric and Gynaecological Society) on 10 February 2024.
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
Invited lecture by Dr Sujoy Dasgupta in the Ultrasound Workshop of the Annual National Conference of Indian Association of Gynaecological Endoscopists (IAGE) held on 15 March 2024 at the Taj Ganges, Varanasi
Invited lecture by Dr Sujoy Dasgupta on "Azoospermia - Evaluation and Management" in a CME on "Standardising Male Factor Evaluation" organised by Indian Fertility Society (IFS) on 20 January 2024.
Are we giving much importance to AMH in infertility practice?Sujoy Dasgupta
Dr Sujoy Dasgupta delivered "Kamini Rao Oration" on "Are we giving much importance to AMH in infertility practice?" in East Zone Yuva FOGSI Conference organized by Imphal Obstetric and Gynaecological Society (IOGS) on 24 December, 2023
Male Infertility-How a Gynaecologist can Manage?Sujoy Dasgupta
Dr Sujoy dasgupta delivered an invited lecture on "Male Infertility-How a Gynaecologist can Manage?" in a CME on "New Frontiers in Infertility" organized by Genome Fertility Centre and Bhagirathi Neotia Woman and Child Care Centre, Kolkata held on 15 December 2023
Endometriosis and Subfertility, Primium non nocereSujoy Dasgupta
Dr Sujoy dasgupta and Dr Arun Madhab Barua were invited to moderate a panel discussion on "Endometriosis and Subfertility, Primium non nocere" in the International Congress on Endometriosis (ICE) on 10 December 2023 at Dhana Dhanya Auditorium, Kolkata
Dr Sujoy Dasgupta delivered an invited talk on "Embryo Transfer" in "Ultrasound Workshop" on 8 December 2023 at Milan, 2023, the conference of all the Obstetric and Gynaecological Societies of West Bengal. This conference was organized by Kalyani Obstetric and Gynaecological Society (KOGS).
Rational Investigations and Management of Male InfertilitySujoy Dasgupta
Dr Sujoy Dasgupta delivered an invited lecture in the annual conference of WMOGS (West Midnapore Obstetric and Gynaecological Society) held on 16 September, 2023
Endometriosis and Subfertility - What to do?Sujoy Dasgupta
Lecture delivered by Dr Sujoy Dasgupta in IPCON 2823, the Mid term conference of ISOPARB (Indian Society of Perinatology and Reproductive Biology) held at Kolkata on 10 September
IVF- How it changed the perspective of Male InfertilitySujoy Dasgupta
This document discusses male infertility and the role of IVF in changing perspectives on male infertility. It provides details on semen analysis reports for multiple patients and discusses what the results indicate about the severity of male factor infertility and next steps. It also discusses evaluating and treating various causes of male infertility like varicocele, cryptorchidism, hormonal abnormalities, and genetic factors. The importance of a detailed history and physical examination is emphasized to properly diagnose the underlying issues.
Male Infertility- How Gynaecologists can manage?Sujoy Dasgupta
Dr Sujoy Dasgupta delivered an invited lecture in a CME organised by JB Pharma with the support from West Midnapore Obst and Gynae Society and Genome Fertility Centre held at Medinipur on 22 July, 2023.
Role of Multivitamins & Antioxidants in Managing Male Infertility Sujoy Dasgupta
Dr Sujoy Dasgupta was invited to deliver a talk on "Role of Multivitamins & Antioxidants in Managing Male Infertility " in a CME organized by Agartala Obstetric and Gynaecological Society and ArEx Laboratory held at Agartala on 8 July 2023
Panel discussion moderated by Dr Sujoy Dasgupta and Dr Sudip Basu on "Troubleshooting in Male Subfertility" in the Andrology Workshop organized by Special Interest Group (SIG) Andrology and Indian Fertility Society (IFS) West Bengal Chapter held on 11 June 2023 at Kolkata
Fertility Management: Synergy between Endoscopists and Fertility SpecialistsSujoy Dasgupta
Dr Sujoy Dasgupta was invited to moderate a panel discussion on "Fertility Management: Synergy between Endoscopists and Fertility Specialists " in a CME by Torrent held on 27 May 2023.
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)Sujoy Dasgupta
Dr Sujoy Dasgupta invited to deliver a lecture on "RPL- ESHRE Guideline" in the Annual Conference of RCOG (Royal College of Obstetricians and Gynaecologists) IRC (International Representative Committee) India East held on 20-21 May, 2023
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
4. Hypoactive Sexual Disorder (HSD)
• F52.4 in ICD-10
• Deficiency or absence of sexual fantasy or
desire for sexual activity
• Females are more affected (40%) than males
(30%)
5. Effects of HSD
• Chronic stress
• Anxiety
• Depression
• Lack of concentration
• Insomnia
• Irritability
• Relationship conflict
• Social withdrawal
6.
7. What your mind does not know, eyes cannot see
Physiological Drugs
Pregnancy Antihypertensives (Beta Blockers)
Menstruation Antiandrogens
Menopause Antiepileptics
Lactation Antidepressants
Systemic Disease Previous bad experience
Diabetes Painful sex
Thyroid disorder Erectile/ Ejaculatory disorders
Hyperprolactinaemia Sexual assault
Hypopituitarism Fear
Gonadal Failure Guilty feeling
Hypertension Fear of STI/ Pregnancy
Fatigue Relationship Problems
Depression Interpersonal conflict
Renal/ Liver Disease Monotony
Infertility Sexual orientation
8. Case 1
• A 52-year-old lady underwent menopause 3
years ago and is no longer interested in sex
• No issue with lubrication or pain
• Feeling difficulty due to obesity
9. Low libido after menopause
• Misconception
• Obesity- Mechanical difficulty in certain sex
positions
• Kegel’s exercise
10. Hormone Therapy for Post-Menopausal
Low Libido
• HRT- may improve general well being and libido
• Vaginal estrogen- With/ systemic HRT
- can be considered when
systemic HRT is contraindicated
• Tibolone- Androgenic
Does not stimulate breast/endometrium
12. Testosterone Preparations
• Oral – Methyltestosterone, micronized
testosterone, DHEA
• Transdermal – Testosterone patches and gels;
testosterone ointment or cream (1% or 2%)
• Injectable or implants – Intramuscular
testosterone injections, testosterone implants
13. Side Effects of Testosterone
• Cosmetic- hirsutism and acne, usually mild
• Irreversible, virilizing changes (eg, voice
deepening, clitoromegaly) are rare, occur only
with excessive dosing.
• Most androgens are aromatized to estrogens;
thus, risks of estrogen therapy are also possible
with androgen treatment.
14. Can we use Testosterone?
• The transdermal testosterone patch is licensed
in Europe for the treatment of HSD in
surgically menopausal women on concomitant
HRT.
• No pharmacologic therapy is currently
approved for the treatment of HSD in
premenopausal or naturally postmenopausal
women and further research is urgently needed
in these populations.
15. Case 2
• Couple happily married for 5 years, having a
baby girl
• Man said “She is not interested in sex” for last
one year
• She said “having enough desire and lubrication
but soon after penetration, lost further interest”
16. Early Orgasmic Response (EOR)
• Equivalent to “premature ejaculation” in men
• Orgasm ≠ ejaculation
• Orgasm ≠ vaginal contraction
• After-play is important
• SSRI- Paroxetine 20 mg- 2 -4 hours before sex
17. Case 3
• A 32-year-old woman presented with low
libido after C section done 6 months ago
• Previous sex life- normal
• Adequate lubrication, penetration, orgasm
18. Postpartum Low Libido
• Change position
• Cross leg
• Kegel’s exercise
• Lubrication
• Episiotomy stitch
• Reconstructive surgery
• Rejuvenate the romance- ambience, bath
together, remove boredom of the bedroom
19. Idiopathic Low Libido
• Lifestyle changes
• Improving body image
• Sex therapy
• Psychotherapy
• Pharmacotherapy
20. Lifestyle Changes
• Reducing stress
• Exercise, yoga or other relaxation techniques,
or support groups
• Regular "date night“- to spend one or two
nights away from family responsibilities
21. Improving Body Image
• Weight reduction
• Bariatric surgery
• Treating pelvic floor dysfunction
22. Sex Therapy
• Educating women and male
• Addressing cultural or religious concerns
• Assigning specific exercises
• Direct patients to a wide range of helpful
resources, including book lists, visual aids, and
devices.
24. Pharmacotherapy
Fibranserin A centrally acting serotonin receptor agonist/antagonist that results
in transient decreases in serotonin and increases in dopamine and
norepinephrine in certain regions of the brain
Only drug approved by the FDA for female sexual dysfunction
common adverse effects- somnolence, dizziness
Buproprion Second line of treatment
As a centrally acting agent, the mechanism of action is likely
similar to that of flibanserin.
off-label nature of use.
Buspirone Can be helpful, particularly in SSRI-induced low libido
PDE5 Inhibitors generally have not proven effective in women.
Studies of sildenafil -inconsistent results
Positive effects have been demonstrated in premenopausal
women with SSRI-associated sexual dysfunction
Ginseng oriental herb
Drug interaction, post menopausal bleeding
Yohimbine Improves genital blood flow
Amyl nitrate headache, palpitation
25. • DHEA might slightly improve sexual function
compared to placebo
• No evidence that DHEA improved sexual function more
than HRT
28. Relationship with new partner
• Research on sexual function consistently
demonstrates- increased libido and pleasure in
new relationships.
• “Where there is marriage without love, there
will be love without marriage”- Benjamin
Franklin
29. Case 4
• Young couple had very happy sex life
• Consulted doctor for Infertility of one year
duration
• Advised Timed Intercourse (TI) from day 12-
18
• Husband suffered from lack of interest and
described sex as “Mechanical entity”
34. Infertile couples with low libido
Testosterone in men-
• Only as HRT in men with hypogonadism
• In male with normogonadotropism, can impair
spermatogenesis
Lubricant in women-
• May be spermicidal
• Best lubricant- adequate foreplay → vaginal
fluid
35. Case 5
• Young couple presented 6 months after
marriage
• Woman not interested in sex after first few
episodes
• O/E- hollow pouch near the urethra
36. Lack of anatomical knowledge
• Female can guide the male
• In dark, its easier to put the food in your own
mouth, rather than trying to feed someone
37. Case 6
• Young woman presented soon after marriage
with loss of libido after first night
• Enough lubrication, penetration, no pain
• Fantasized about man with “large penis”
38. Size matters ???
• Archer is known
by his aim, not by
the length of his
arrow path
39. History taking in low libido
• Misconceptions, unrealistic expectations
• Disturbed interpersonal relationship
• Details of sequences-
Desire → Erection/ Lubrication → Penetration
→ Orgasm
• Orgasm during masturbation
• Orgasm with other partners
43. Differences in sexuality
Female
• The majority of adult men think
about sex at least once a day
• Want sex at the start of a
relationship, in the middle of it,
and after many years of it
• Attach little emotion
• Want lots of sex only
Male
• Only about one-quarter of women
think about sex daily
• Want commitment throughout
the relationship
• Lots of emotion to sexual
encounter
• Want lots of sex with the
partners they love, in suitable
ambience
46. Take Home Messages
• Low libido is under-reported, under-evaluated,
under-treated
• Proper history taking will disclose the diagnosis
in most cases
• Problems- in between two legs !!!
• Problems- in between two ears !!!
• Both the partners should be seen together
• Non-pharmacological interventions often work
well